It's now possible to diagnose strokes from scans sent to a smart-phone, using a newly developed Candian app. Researchers found that the sensitivity and specificity of detecting intraparenchymal hemorrhage were 100 percent for the iOS device.
If radiologists need another reason to justify their iPhone, it just arrived. It's now possible to diagnose strokes from scans sent to a smart-phone, using a newly developed Candian app, with positive implications for teleradiology and rural communities.
A retrospective study published May 6th in the Journal of Medical Internet Research, had two neuroradiologists reading 120 recent consecutive nonconrast CT (NCCT) brain scans, plus 70 CT angiograms (CTA) head scans from the Calgary Stroke Program database. One reader used a diagnostic workstation, the other used an iPhone or iPod Touch (iOS device). Readers looked at NCCT scans for early signs of infarction, including early parenchymal ischemic changes and dense vessel sign, excluding acute intraparenchymal hemorrhage and stroke mimics. They evaluated CTA scans for any intracranial vessel occlusion, then compared the diagnoses from both platforms.
Researchers found that the sensitivity and specificity of detecting intraparenchymal hemorrhage were 100 percent for the iOS device. As for the sensitivity, specificity and accuracy of detecting acute parenchymal ischemic change, those figures were 94.1 percent, 100 percent and 98.09 percent respectively for the first reader, and 97.05 percent, 100 percent and 99.04 percent for the second reader. In detecting vessel occlusion on CTA, the sensitivity, specificity, and accuracy were 94.4 percent, 100 percent and 98.46 percent for both readers. There was also no significant difference in the amount of time it took them to read the images on the iOS compared to the workstation.
The iOS application can view both 2-D and 3-D images, and can be manipulated by the user, with results in seconds. No patient data is stored on the iOS device, rather it’s stored on a remote, secure server. This study was designed by Mayank Goyal, MD, of the Hotchkiss Brain Institute (HBI), and the iPhone software technology was originally developed by Ross Mitchell, PhD, and others at HBI. It was then enhanced and commercialized by Calgary Scientific Inc.
The app is ResolutionMD Mobile, which can also be used on Android smart-phones and iPads, as well as web-based browsers. The computing work is done on a server, then streaming the images to the smart-phone in real time. Health Canada approved the app in April 2010, so doctors there can make primary diagnoses using it. It’s since reportedly been licensed to medical imaging companies and 50,000 hospitals, so doctors should have access to it within the next two years.
CT Study: AI Algorithm Comparable to Radiologists in Differentiating Small Renal Masses
May 14th 2024An emerging deep learning algorithm had a lower AUC and sensitivity than urological radiologists for differentiating between small renal masses on computed tomography (CT) scans but had a 21 percent higher sensitivity rate than non-urological radiologists, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears AI-Powered Qualitative Perfusion Mapping for Cone-Beam CT
May 6th 2024Reportedly validated in more than 10 clinical trials, the AngioFlow perfusion imaging software enables timely identification of brain regions with cerebral blood flow reduction and those with significant hypoperfusion.
Can a CT-Based Radiomics Model Bolster Detection of Malignant Thyroid Nodules?
May 3rd 2024A computed tomography (CT)-based radiomics model that includes 28 radiomic features showed significantly higher accuracy, sensitivity, and specificity than conventional CT in differentiating benign and malignant thyroid nodules, according to newly published research.